Company news: SDI and Cegedim

Share this article:

SDI and Cegedim Strategic Data are partnering on a market research service that tracks selling activities in the oncology therapeutic market. The Oncology Selling Audit, a monthly service to launch in January, will “provide nationally projected measures of personal selling in the oncology market, including competitive corporate calls, details, messages, and promotional spending,” and will allow analysis by tumor type, staging, and modalities, the two market research firms said.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.